Format
Sort by
Items per page

Send to

Choose Destination

Best matches for ganoderma lucidum cancer:

Search results

Items: 1 to 20 of 366

1.

Ganoderma lucidum Polysaccharides as An Anti-cancer Agent.

Sohretoglu D, Huang S.

Anticancer Agents Med Chem. 2017 Nov 13. doi: 10.2174/1871520617666171113121246. [Epub ahead of print]

PMID:
29141563
2.

Ethyl lucidenates A reverses P-glycoprotein mediated vincristine resistance in K562/A02 cells.

Li P, Chen SY, Shen SX, Liu LX, Xu JH, Zhang ZQ.

Nat Prod Res. 2017 Nov 13:1-4. doi: 10.1080/14786419.2017.1402323. [Epub ahead of print]

PMID:
29130339
3.

Ganoderma lucidum polysaccharide inhibits prostate cancer cell migration via the protein arginine methyltransferase 6 signaling pathway.

Zhao X, Zhou D, Liu Y, Li C, Zhao X, Li Y, Li W.

Mol Med Rep. 2017 Oct 26. doi: 10.3892/mmr.2017.7904. [Epub ahead of print]

PMID:
29115463
4.

Medicinal Mushrooms (PDQ®): Patient Version.

PDQ Integrative, Alternative, and Complementary Therapies Editorial Board.

PDQ Cancer Information Summaries [Internet]. Bethesda (MD): National Cancer Institute (US); 2002-.
2017 Oct 24.

5.

Molecular docking based screening of triterpenoids as potential G-quadruplex stabilizing ligands with anti-cancer activity.

Sillapapongwarakorn S, Yanarojana S, Pinthong D, Thithapandha A, Ungwitayatorn J, Supavilai P.

Bioinformation. 2017 Sep 30;13(9):284-292. doi: 10.6026/97320630013284. eCollection 2017.

6.

Ganoderic acid, lanostanoid triterpene: a key player in apoptosis.

Gill BS, Navgeet, Mehra R, Kumar V, Kumar S.

Invest New Drugs. 2017 Oct 28. doi: 10.1007/s10637-017-0526-0. [Epub ahead of print] Review.

PMID:
29081024
7.

Overview of Ganoderma sinense polysaccharide-an adjunctive drug used during concurrent Chemo/Radiation therapy for cancer treatment in China.

Jiang Y, Chang Y, Liu Y, Zhang M, Luo H, Hao C, Zeng P, Sun Y, Wang H, Zhang L.

Biomed Pharmacother. 2017 Oct 19;96:865-870. doi: 10.1016/j.biopha.2017.09.060. [Epub ahead of print] Review.

PMID:
29078264
9.

The ethanol extracts of sporoderm-broken spores of Ganoderma lucidum inhibit colorectal cancer in vitro and in vivo.

Li K, Na K, Sang T, Wu K, Wang Y, Wang X.

Oncol Rep. 2017 Nov;38(5):2803-2813. doi: 10.3892/or.2017.6010. Epub 2017 Sep 27.

PMID:
29048673
10.

Medicinal Mushrooms (PDQ®): Health Professional Version.

PDQ Integrative, Alternative, and Complementary Therapies Editorial Board.

PDQ Cancer Information Summaries [Internet]. Bethesda (MD): National Cancer Institute (US); 2002-.
2017 Oct 6.

11.

[Anti-tumor target prediction and activity verification of Ganoderma lucidum triterpenoids].

Du GH, Wang HX, Yan Z, Liu LY, Chen RY.

Zhongguo Zhong Yao Za Zhi. 2017 Feb;42(3):517-522. doi: 10.19540/j.cnki.cjcmm.20161222.069. Chinese.

PMID:
28952258
12.

Anti-inflammatory properties of GLPss58, a sulfated polysaccharide from Ganoderma lucidum.

Zhang K, Liu Y, Zhao X, Tang Q, Dernedde J, Zhang J, Fan H.

Int J Biol Macromol. 2017 Sep 7. pii: S0141-8130(17)32352-8. doi: 10.1016/j.ijbiomac.2017.09.015. [Epub ahead of print]

PMID:
28890375
13.
14.

Feeding of the water extract from Ganoderma lingzhi to rats modulates secondary bile acids, intestinal microflora, mucins, and propionate important to colon cancer.

Yang Y, Nirmagustina DE, Kumrungsee T, Okazaki Y, Tomotake H, Kato N.

Biosci Biotechnol Biochem. 2017 Sep;81(9):1796-1804. doi: 10.1080/09168451.2017.1343117. Epub 2017 Jun 29.

PMID:
28661219
15.

Ganoderma lucidum targeting lung cancer signaling: A review.

Gill BS, Navgeet, Kumar S.

Tumour Biol. 2017 Jun;39(6):1010428317707437. doi: 10.1177/1010428317707437. Review.

PMID:
28653896
16.

Ganoderma lucidum (Reishi) suppresses proliferation and migration of breast cancer cells via inhibiting Wnt/β-catenin signaling.

Zhang Y.

Biochem Biophys Res Commun. 2017 Jul 8;488(4):679-684. doi: 10.1016/j.bbrc.2017.04.086. Epub 2017 Apr 17.

PMID:
28427938
17.

The solid-state fermentation of Artemisia capillaris leaves with Ganoderma lucidum enhances the anti-inflammatory effects in a model of atopic dermatitis.

Son HU, Lee S, Heo JC, Lee SH.

Int J Mol Med. 2017 May;39(5):1233-1241. doi: 10.3892/ijmm.2017.2945. Epub 2017 Apr 7.

18.

Screening and Analysis of the Marker Components in Ganoderma lucidum by HPLC and HPLC-MS<sup>n</sup> with the Aid of Chemometrics.

Wu L, Liang W, Chen W, Li S, Cui Y, Qi Q, Zhang L.

Molecules. 2017 Apr 6;22(4). pii: E584. doi: 10.3390/molecules22040584.

19.

Anticarcinogenic effects of water extract of sporoderm-broken spores of Ganoderma lucidum on colorectal cancer in vitro and in vivo.

Na K, Li K, Sang T, Wu K, Wang Y, Wang X.

Int J Oncol. 2017 May;50(5):1541-1554. doi: 10.3892/ijo.2017.3939. Epub 2017 Mar 29.

20.

Ganoderic acid targeting nuclear factor erythroid 2-related factor 2 in lung cancer.

Gill BS, Kumar S, Navgeet.

Tumour Biol. 2017 Mar;39(3):1010428317695530. doi: 10.1177/1010428317695530.

PMID:
28349780

Supplemental Content

Loading ...
Support Center